SYNDROS is approved for cancer patients who experience breakthrough nausea and vomiting while undergoing chemotherapy treatment and have failed to adequately respond to conventional antiemetic treatments.
Patients on antiemetic treatments sometimes still experience nausea and vomiting while receiving chemotherapy. This ailment, often referred to as chemotherapy-induced nausea and vomiting (CINV), is still prevalent despite conventional treatment. SYNDROS may be able to help.
Traditionally, an antiemetic treatment is prescribed to patients who experience nausea or vomiting for the side effects of chemotherapy. Unfortunately, many patients an antiemetic medications still experience nausea and vomiting while recieving chemotherapy. If you are experiencing breakthrough chemotherapy-induced nausea and vomiting (CINV), it's time to speak with your oncologist.
Many patients prefer a liquid medication like SYNDROS.
If you take anti-nausea medicine while undergoing chemotherapy, and it's not working, let your healthcare provider know the following:
The more information you can give to your healthcare provider, the better they will be able to understand your CINV and find you the best treatment options for your nausea and vomiting.